pmcc logo sml

 

 Here are the staff publications for April 2023.

Compiled by the Health Sciences Library (RMH, RWH, PMCC & Victorian Mental Health) 1st May 2023.

 

  1. Admojo L, Korte J, Anderson N, Phillips C, Caspersz L, Lasocki A. Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery. J Med Imaging Radiat Oncol 2023;67:292-8.
  2. Andrew EC, Khaw SL, Hanna D, Conyers R, Fleming J, Hughes D, Toro C, Wang SS, Weerdenburg H, Anderson S, Cole T, Haeusler GM. Density of antibiotic use and infectious complications in pediatric allogeneic hematopoietic cell transplantation. Transpl Infect Dis 2023;25:e14018.
  3. Au AE, Corbin J, Lebois M, Gangatirkar P, Yassinson F, Hyslop SR, Cannon P, Mason KD, Li-Wai-Suen CSN, Garnham AL, Moujalled D, Cimmino L, Alexander WS, Josefsson EC. Proinflammatory microenvironment promotes lymphoma progression in mice with high megakaryocyte and TPO levels. Blood Adv 2023;7:1560-71.
  4. Best S, Long JC, Fehlberg Z, Theodorou T, Hatem S, Archibald A, Braithwaite J. The more you do it, the easier it gets: using behaviour change theory to support health care professionals offering reproductive genetic carrier screening. Eur J Hum Genet 2023;31:430-44.
  5. Buckingham PLM, Hussainy S, Soon J, Norman WV, Bateson D, Mazza D. Improving access to quality contraceptive counselling in community pharmacy: examining the knowledge, attitudes and practices of community pharmacists in Australia. BMJ Sex Reprod Health 2023;49:87-96.
  6. Campbell BA, Brown R, Lambertini A, Hofman MS, Bressel M, Seymour JF, Wirth A, MacManus M, Dickinson M. Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation? Br J Haematol 2023;201:502-9.
  7. Chan TH, Haworth A, Wang A, Osanlouy M, Williams S, Mitchell C, Hofman MS, Hicks RJ, Murphy DG, Reynolds HM. Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy. EJNMMI Res 2023;13:34.
  8. Chang A, Botteri E, Gillis RD, Löfling L, Le CP, Ziegler AI, Chung NC, Rowe MC, Fabb SA, Hartley BJ, Nowell CJ, Kurozumi S, Gandini S, Munzone E, Montagna E, Eikelis N, Phillips SE, Honda C, Masuda K, Katayama A, Oyama T, Cole SW, Lambert GW, Walker AK, Sloan EK. Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer. Sci Transl Med 2023;15:eadf1147.
  9. De Silva DL, Stafford L, Skandarajah AR, Sinclair M, Devereux L, Hogg K, Kentwell M, Park A, Lal L, Zethoven M, Jayawardana MW, Chan F, Butow PN, James PA, Mann GB, Campbell IG, Lindeman GJ. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care. Med J Aust 2023;218:368-73.
  10. Desai J, Fong P, Moreno V, Frentzas S, Meniawy T, Markman B, Voskoboynik M, Rahman T, Budha N, Wu J, Marlow J, Yang S, Calvo E, Martin-Liberal J. A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours. Br J Cancer 2023;128:1418-28.
  11. Downie E, May J, Stevens S, Liu DS. Towards standardized perioperative chemoprophylaxis in major elective abdominal surgery. ANZ J Surg 2023;93:817-8.
  12. Fidelito G, De Souza DP, Niranjan B, De Nardo W, Keerthikumar S, Brown K, Taylor RA, Watt MJ. Multi-substrate Metabolic Tracing Reveals Marked Heterogeneity and Dependency on Fatty Acid Metabolism in Human Prostate Cancer. Mol Cancer Res 2023;21:359-73.
  13. Flensburg C, Oshlack A, Majewski IJ. Detecting copy number alterations in RNA-Seq using SuperFreq. Bioinformatics 2021;37:4023-32.
  14. Gearing PF, Hawke JA, Mohan H, Heriot AG, Khan A, Beaumont A, Laing E, Waters PS. Perioperative nutritional assessment and interventions in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): A systematic review. Eur J Surg Oncol 2023;49:902-17.
  15. Gonzalez-Fierro C, Fonte C, Dufourd E, Cazaentre V, Aydin S, Engelhardt B, Caspi RR, Xu B, Martin-Blondel G, Spicer JA, Trapani JA, Bauer J, Liblau RS, Bost C. Effects of a Small-Molecule Perforin Inhibitor in a Mouse Model of CD8 T Cell-Mediated Neuroinflammation. Neurol Neuroimmunol Neuroinflamm 2023;10.
  16. Hancock JL, Kalimutho M, Straube J, Lim M, Gresshoff I, Saunus JM, Lee JS, Lakhani SR, Simpson KJ, Bush AI, Anderson RL, Khanna KK. COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. J Exp Clin Cancer Res 2023;42:90.
  17. Hayes S, Obermair A, Mileshkin L, Davis A, Gordon LG, Eakin E, Janda M, Beesley VL, Barnes EH, Spence RR, Sandler C, Jones T, Vagenas D, Webb P, Andrews J, Brand A, Lee YC, Friedlander M, Pumpa K, O'Neille H, Williams M, Stockler M. Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial. BMJ Open 2023;13:e067925.
  18. Heazlewood SY, Ahmad T, Cao B, Cao H, Domingues M, Sun X, Heazlewood CK, Li S, Williams B, Fulton M, White JF, Nebl T, Nefzger CM, Polo JM, Kile BT, Kraus F, Ryan MT, Sun YB, Choong PFM, Ellis SL, Anko ML, Nilsson SK. High ploidy large cytoplasmic megakaryocytes are hematopoietic stem cells regulators and essential for platelet production. Nat Commun 2023;14:2099.
  19. Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, Peters S, Planchard D, Smit EF, Solomon BJ, Veronesi G, Reck M, This email address is being protected from spambots. You need JavaScript enabled to view it. EGCEa. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2023;34:358-76.
  20. Hoe V, Yao HH, Gough K, O'Connell HE. Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence. BJUI Compass 2023;4:269-76.
  21. Hollizeck S, Wong SQ, Solomon B, Chandrananda D, Dawson SJ. Custom workflows to improve joint variant calling from multiple related tumour samples: FreeBayesSomatic and Strelka2Pass. Bioinformatics 2021;37:3916-9.
  22. Iravani A, Wallace R, Lo SN, Galligan A, Weppler AM, Hicks RJ, Sandhu S. FDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab. Radiology 2023;307:e221180.
  23. Kashyap R, Ravi Kumar AS. Could FAP-Targeted Molecular Imaging Replace (18)F-FDG for Standard-of-Care Oncologic PET? J Nucl Med 2023;64:623-4.
  24. La Marca JE, Ely RW, Diepstraten ST, Burke P, Kelly GL, Humbert PO, Richardson HE. A Drosophila chemical screen reveals synergistic effect of MEK and DGKalpha inhibition in Ras-driven cancer. Dis Model Mech 2023;16.
  25. Lai-Kwon J, Inderjeeth AJ, Lisy K, Sandhu S, Rutherford C, Jefford M. Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review. Eur J Cancer 2023;184:83-105.
  26. Leong SW, Wang J, Okuda KS, Su Q, Zhang Y, Abas F, Chia SL, Yusoff K. Discovery of a novel dual functional phenylpyrazole-styryl hybrid that induces apoptotic and autophagic cell death in bladder cancer cells. Eur J Med Chem 2023;254:115335.
  27. Luen SJ, Viale G, Nik-Zainal S, Savas P, Kammler R, Dell'Orto P, Biasi O, Degasperi A, Brown LC, Lang I, MacGrogan G, Tondini C, Bellet M, Villa F, Bernardo A, Ciruelos E, Karlsson P, Neven P, Climent M, Muller B, Jochum W, Bonnefoi H, Martino S, Davidson NE, Geyer C, Chia SK, Ingle JN, Coleman R, Solbach C, Thurlimann B, Colleoni M, Coates AS, Goldhirsch A, Fleming GF, Francis PA, Speed TP, Regan MM, Loi S. Genomic characterisation of hormone receptor-positive breast cancer arising in very young women. Ann Oncol 2023;34:397-409.
  28. Mehdi AM, Zhou C, Turrell G, Walpole E, Porceddu S, Frazer IH, Chandra J. HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer. Cancer Gene Ther 2023;30:629-40.
  29. Mentzel F, Paino J, Barnes M, Cameron M, Corde S, Engels E, Kröninger K, Lerch M, Nackenhorst O, Rosenfeld A, Tehei M, Tsoi AC, Vogel S, Weingarten J, Hagenbuchner M, Guatelli S. Accurate and Fast Deep Learning Dose Prediction for a Preclinical Microbeam Radiation Therapy Study Using Low-Statistics Monte Carlo Simulations. Cancers (Basel) 2023;15.
  30. Meyran D, Zhu JJ, Butler J, Tantalo D, MacDonald S, Nguyen TN, Wang M, Thio N, D'Souza C, Qin VM, Slaney C, Harrison A, Sek K, Petrone P, Thia K, Giuffrida L, Scott AM, Terry RL, Tran B, Desai J, Prince HM, Harrison SJ, Beavis PA, Kershaw MH, Solomon B, Ekert PG, Trapani JA, Darcy PK, Neeson PJ. T(STEM)-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models. Sci Transl Med 2023;15:eabk1900.
  31. Moi D, Zeng B, Minnie SA, Bhatt R, Wood J, Sester DP, Mazzieri R, Dolcetti R. Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology models. Front Immunol 2023;14:1127896.
  32. Nguyen THO, Rowntree LC, Allen LF, Chua BY, Kedzierski L, Lim C, Lasica M, Tennakoon GS, Saunders NR, Crane M, Chee L, Seymour JF, Anderson MA, Whitechurch A, Clemens EB, Zhang W, Chang SY, Habel JR, Jia X, McQuilten HA, Minervina AA, Pogorelyy MV, Chaurasia P, Petersen J, Menon T, Hensen L, Neil JA, Mordant FL, Tan HX, Cabug AF, Wheatley AK, Kent SJ, Subbarao K, Karapanagiotidis T, Huang H, Vo LK, Cain NL, Nicholson S, Krammer F, Gibney G, James F, Trevillyan JM, Trubiano JA, Mitchell J, Christensen B, Bond KA, Williamson DA, Rossjohn J, Crawford JC, Thomas PG, Thursky KA, Slavin MA, Tam CS, Teh BW, Kedzierska K. Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells. Cell Rep Med 2023;4:101017.
  33. Palmieri M, Catimel B, Mouradov D, Sakthianandeswaren A, Kapp E, Ang CS, Williamson NA, Nowell CJ, Christie M, Desai J, Gibbs P, Burgess AW, Sieber OM. PI3Kalpha Translocation Mediates Nuclear PtdIns(3,4,5)P(3) Effector Signaling in Colorectal Cancer. Mol Cell Proteomics 2023;22:100529.
  34. Pearson EJ, Denehy L, Edbrooke L. Identifying strategies for implementing a clinical guideline for cancer-related fatigue: a qualitative study. BMC Health Serv Res 2023;23:395.
  35. Penfold SN, Dell'Oro M, Gorayski P, Hwang E, Le H, Penfold M, Sykes J, Vu H, Yeo A. Proton-to-photon comparative treatment planning guidelines for the Australian context. J Med Imaging Radiat Oncol 2023;67:320-8.
  36. Sadras T, Jalud FB, Kosasih HJ, Horne CR, Brown LM, El-Kamand S, de Bock CE, McAloney L, Ng AP, Davidson NM, Ludlow LEA, Oshlack A, Cowley MJ, Khaw SL, Murphy JM, Ekert PG. Unusual PDGFRB fusion reveals novel mechanism of kinase activation in Ph-like B-ALL. Leukemia 2023;37:905-9.
  37. Schettini F, Martínez-Sáez O, Falato C, De Santo I, Conte B, Garcia-Fructuoso I, Gomez-Bravo R, Seguí E, Chic N, Brasó-Maristany F, Paré L, Vidal M, Adamo B, Muñoz M, Pascual T, Ciruelos E, Perou CM, Carey LA, Prat A. Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis. ESMO Open 2023;8:101214.
  38. Todio E, Sharp J, Morrow A, Taylor N, Schofield P, Mazariego C. Examining the effectiveness and implementation of patient treatment decision-aid tools for men with localised prostate cancer: A systematic review. Psychooncology 2023;32:469-91.
  39. Tutty E, Forbes Shepherd R, Hoskins C, Purvis R, Shanahan M, Boussioutas A, Forrest LE. Becoming and being a parent with an inherited predisposition to diffuse gastric cancer: A qualitative study of young adults with a CDH1 pathogenic variant. J Psychosoc Oncol 2023;41:286-302.
  40. von Borstel A, Nguyen TH, Rowntree LC, Ashhurst TM, Allen LF, Howson LJ, Holmes NE, Smibert OC, Trubiano JA, Gordon CL, Cheng AC, Kent SJ, Rossjohn J, Kedzierska K, Davey MS. Circulating effector gammadelta T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals. Immunol Cell Biol 2023;101:321-32.
  41. Walker R, Mahmood K, Joo JE, Clendenning M, Georgeson P, Como J, Joseland S, Preston SG, Antill Y, Austin R, Boussioutas A, Bowman M, Burke J, Campbell A, Daneshvar S, Edwards E, Gleeson M, Goodwin A, Harris MT, Henderson A, Higgins M, Hopper JL, Hutchinson RA, Ip E, Isbister J, Kasem K, Marfan H, Milnes D, Ng A, Nichols C, O'Connell S, Pachter N, Pope BJ, Poplawski N, Ragunathan A, Smyth C, Spigelman A, Storey K, Susman R, Taylor JA, Warwick L, Wilding M, Williams R, Win AK, Walsh MD, Macrae FA, Jenkins MA, Rosty C, Winship IM, Buchanan DD. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome. J Transl Med 2023;21:282.
  42. Wang C, Block MS, Cunningham JM, Sherman ME, McCauley BM, Armasu SM, Vierkant RA, Traficante N, Australian Ovarian Cancer Study G, Talhouk A, Ramus SJ, Pejovic N, Kobel M, Jorgensen BD, Garsed DW, Fereday S, Doherty JA, Ariyaratne D, Anglesio MS, Widschwendter M, Pejovic T, Bosquet JG, Bowtell DD, Winham SJ, Goode EL. Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma. Cancer Epidemiol Biomarkers Prev 2023;32:542-9.
  43. Webb F, Morey A, Mahler-Hinder C, Georgousopoulou E, Koo R, Pati N, Talaulikar D. Comprehensive FISH testing using FFPE tissue microarray of primary lymph node tissue identifies secondary cytogenetic abnormalities in Mantle Cell Lymphoma. Cancer Genet 2023;274-275:75-83.
  44. Wolyniec K, O'Callaghan C, Fisher K, Jessica S, Tothill RW, Bowtell D, Linda M, Schofield P. A qualitative study of patients with Cancer of Unknown Primary: Perceptions of communication, understanding of diagnosis and genomic testing, and information needs. Psychooncology 2023;32:589-96.
  45. Zhang Q, Hamilton D, Conway P, Xie SJ, Haghighi N, Lasocki A. Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact intracranial metastases. J Med Imaging Radiat Oncol 2023;67:308-19.
  46. Zhong Y, McKenna L, Copnell B, Zhao W, Moss C. Professional Adaptation Experiences of Chinese Migrant Nurses in Australia: A Qualitative Study. West J Nurs Res 2023:1939459231167711.

Contact Details and Hours

(03) 9138 0580
(03) 9342 8615
rmh.libinfo@mh.org.au
M - F: 8:30am - 5pm

Library Manager

Susan Monaghan

susan.monaghan@mh.org.au

Health Sciences Library

Royal Melbourne Hospital – City Campus

Ground floor - North

Grattan Street

PARKVILLE, VIC 3050

Learning Resource Centre

Level 7A, Peter MacCallum Cancer Centre

305 Grattan Street

MELBOURNE, VIC 3000